Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.5 PLN | -4.13% | -2.99% | -8.45% |
Feb. 29 | Pharmena S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
Sales 2022 | 19.02M 4.71M | Sales 2023 | 299K 74.11K | Capitalization | 79.08M 19.6M |
---|---|---|---|---|---|
Net income 2022 | -1M -248K | Net income 2023 | 28M 6.94M | EV / Sales 2022 | 3.73 x |
Net Debt 2022 | 8.55M 2.12M | Net cash position 2023 | 22.05M 5.47M | EV / Sales 2023 | 191 x |
P/E ratio 2022 |
-39.7
x | P/E ratio 2023 |
2.73
x | Employees | 15 |
Yield 2022 * |
-
| Yield 2023 |
12% | Free-Float | 29.7% |
1 day | -4.13% | ||
1 week | -2.99% | ||
Current month | -22.06% | ||
1 month | -18.55% | ||
3 months | -10.71% | ||
6 months | +5.52% | ||
Current year | -8.45% |
Managers | Title | Age | Since |
---|---|---|---|
Konrad Palka
CEO | Chief Executive Officer | - | 02-11-11 |
Chief Tech/Sci/R&D Officer | - | 02-11-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | - | |
Director/Board Member | 61 | - | |
Jacek Dauenhauer
BRD | Director/Board Member | 56 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 6.5 | -4.13% | 12 070 |
24-04-25 | 6.78 | -0.88% | 5,726 |
24-04-24 | 6.84 | +1.18% | 8,962 |
24-04-23 | 6.76 | +0.30% | 19,211 |
24-04-22 | 6.74 | -0.59% | 5,335 |
Delayed Quote Warsaw S.E., April 26, 2024 at 11:55 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-8.45% | 18.73M | |
-3.33% | 250B | |
+10.09% | 19.15B | |
0.00% | 17.54B | |
-1.32% | 10.84B | |
-7.73% | 10.22B | |
+3.86% | 6.53B | |
+9.76% | 6B | |
-0.06% | 4.41B | |
-16.98% | 3.78B |
- Stock Market
- Equities
- PHR Stock